Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 24% to $0.21 Thursay afternoon after the company announced a 1-for-22 reverse stock split.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that it will effect a